Article info
PostScript
Letters
Neonatal drug trials: impact of EU and US paediatric regulations
- Correspondence to Professor Evelyne Jacqz-Aigrain, Department of Paediatric Pharmacology and Pharmacogénétics, Hôpital Robert Debré, 48 boulevard Serurier, Paris 75019, France; evelyne.jacqz-aigrain{at}rdb.aphp.fr
Citation
Neonatal drug trials: impact of EU and US paediatric regulations
Publication history
- Accepted April 7, 2014
- First published May 3, 2014.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions